MediFind

Find a Doctor

Edward V. Loftus

Mayo Clinic
Gastroenterology, Internal Medicine
Male
Practicing approx. 32 years

Bio


Edward Loftus is a Gastroenterologist and an Internal Medicine specialist in Rochester, Minnesota. He has been an author on 331 peer reviewed articles in the past 15 years. Dr. Loftus's top three areas of expertise are Crohn's Disease, Ulcerative Colitis, and Viral Gastroenteritis. He is licensed to treat patients in MN, WI, IA, and AZ.

Contact

Rochester, MN 55905, US

Latest Research


Latest Advance
Study
  • Condition: De Novo Inflammatory Bowel Disease (IBD) and Obesity
  • Journal: Alimentary pharmacology & therapeutics
  • Treatment Used: Bariatric Surgery or Weight Loss Medications
  • Number of Patients: 5275870
  • Published —
This study investigated the risk of de novo IBD in patients undergoing bariatric surgery or using weight loss medications to treat obesity.
Latest Advance
Study
  • Condition: Crohn's Disease
  • Journal: Gastroenterology
  • Treatment Used: Upadacitinib
  • Number of Patients: 220
  • Published —
The purpose of the study was to evaluate the effectiveness and safety of upadacitinib for the treatment of Crohn's disease.
Latest Advance
Study
  • Condition: Moderate-To-Severe Ulcerative Colitis
  • Journal: The New England journal of medicine
  • Treatment Used: Vedolizumab vs. Adalimumab
  • Number of Patients: 769
  • Published —
This study compared the effectiveness of vedolizumab (monoclonal antibody drug) versus adalimumab (drug used for various types of arthritis) in adults with moderately to severely active ulcerative colitis (inflammation and ulcers of the colon and rectum).
Latest Advance
Study
  • Condition: Adalimumab-naïve Patients with Crohn's Disease
  • Journal: Inflammatory bowel diseases
  • Treatment Used: Adalimumab
  • Number of Patients: 2057
  • Published —
This study assessed long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice in patients with Crohn's disease.
Latest Advance
Study
  • Condition: Crohn's Disease or Ulcerative Colitis
  • Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • Treatment Used: Vedolizumab
  • Number of Patients: 1087
  • Published —
The study researched the effects of disease duration on the outcomes of using Vedolizumab to treat Crohn's disease or ulcerative colitis.
Latest Advance
Study
  • Condition: Ulcerative colitis
  • Journal: Gastroenterology
  • Treatment Used: Abrilumab
  • Number of Patients: 354
  • Published —
This study evaluated the safety and efficacy of abrilumab for moderate-to-severe ulcerative colitis.
Latest Advance
Study
  • Condition: Colon Surgery Risk in Patients with Inflammatory Bowel Disease (IBD) With Clostridium Difficile Infection (CDI)
  • Journal: Inflammatory bowel diseases
  • Treatment Used: Corticosteroids vs. Immunomodulators or Biologics
  • Number of Patients: 137
  • Published —
This study assessed factors associated with adverse outcomes in inflammatory bowel disease (IBD) with Clostridium difficile infection (CDI), including the role of escalating or de-escalating inflammatory bowel disease therapy and Clostridium difficile infection treatment.
Latest Advance
Study
  • Condition: Inflammatory Bowel Disease
  • Journal: Journal of gastroenterology
  • Treatment Used: Vedolizumab
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using vedolizumab to treat inflammatory bowel disease.
Latest Advance
Study
  • Condition: Inflammatory Bowel Disease (IBD)
  • Journal: Inflammatory bowel diseases
  • Treatment Used: Vedolizumab
  • Number of Patients: 146
  • Published —
This study evaluated the complication rates of patients with inflammatory bowel disease (intestinal disorders that cause prolonged inflammation of the digestive tract; IBD) treated with vedolizumab.
Latest Advance
Study
  • Condition: 827 Biologic-Naïve Patients with Crohn's Disease (CD)
  • Journal: Alimentary pharmacology & therapeutics
  • Treatment Used: Infliximab vs. Adalimumab
  • Number of Patients: 2908
  • Published —
This study compared the effectiveness and safety of adalimumab and infliximab in biologic-naïve patients with Crohn's disease.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Journal of Crohn's & colitis
  • Published —
Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
Publication
Study
  • Journal: Journal of clinical gastroenterology
  • Published —
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.

Contact

Rochester, MN 55905, US

Affiliations

  • Mayo Clinic Hospital Rochester

Credentials

  • Licenses
    Internal Medicine in MN
  • Board Certifications
    Gastroenterology

Insurance

Contact them to find out if they accept your insurance plan.